2023 cancer research highlights: Drug development at its best
Drug Discovery World
FEBRUARY 28, 2024
CRISPR and brain cancer Meanwhile, elsewhere in the US, another exciting development – using CRISPR as a therapeutic approach – has possibilities for tackling brain cancer. The drug, MOv18 IgE (an anti-folate receptor alpha IgE antibody), was developed by researchers at King’s College London. expressing cancers.
Let's personalize your content